Search Results - "MARTINEZ, FRANCISCA INIESTA"

Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis by Mutukula, Naresh, Man, Zhiqiu, Takahashi, Yuta, Iniesta Martinez, Francisca, Morales, Mariana, Carreon-Guarnizo, Ester, Hernandez Clares, Rocio, Garcia-Bernal, David, Martinez Martinez, Llanos, Lajara, Jeronimo, Nuñez Delicado, Estrella, Meca Lallana, Jose E., Izpisua Belmonte, Juan Carlos

“…•Pluripotent stem cells (hiPSCs) were generated from healthy individuals and patients with RRMS and PPMS.•All the generated hiPSC lines displayed the…”
Get full text

Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis by Sánchez Martínez, Iria, Cerdán Sánchez, María, López Román, Javier, Iniesta Martínez, Francisca, Carreón-Guarnizo, Ester, Meca Lallana, Jose-Eustasio, Zafrilla Rentero, Pilar

“…Multiple sclerosis is a chronic, demyelinating, and degenerative disease of the central nervous system with an immune-based pathologic origin. The present…”
Get full text

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study by Millán-Pascual, Jorge, Valero-López, Gabriel, Iniesta-Martinez, Francisca, Hellin-Gil, Maria Fuensanta, Jimenez-Veiga, Judith, López-Tovar, Isabel Alejandra, Morales-Ortiz, Ana, Meca-Lallana, José. E.

“…Introduction The risk of SARS-CoV-2 infection or severe coronavirus disease 2019 (COVID-19) has been shown to increase in patients with multiple sclerosis…”
Get full text

Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications by LÓPEZ-LUCAS, MARÍA DOLORES, PACHÓN-PEÑA, GISELA, GARCÍA-HERNÁNDEZ, ANA MARÍA, PARRADO, ANTONIO, SÁNCHEZ-SALINAS, DARÍO, GARCÍA-BERNAL, DAVID, ALGUERÓ, MARIA DEL CARMEN, MARTINEZ, FRANCISCA INIESTA, BLANQUER, MIGUEL, CABAÑAS-PERIANES, VALENTÍN, MOLINA-MOLINA, MAR, ASÍN-AGUILAR, CIRA, MORALEDA, JOSÉ M, SACKSTEIN, ROBERT

“…Abstract Background The regenerative and immunomodulatory properties of human mesenchymal stromal cells (hMSCs) have raised great hope for their use in cell…”
Get full text

NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells by ODQVIST, Lina, SANCHEZ-BEATO, Margarita, SOLERA-ARROYO, Juan Carlos, RAMOS-ASENSIO, Rafael, FLORES, Teresa, MENARGUEZ PALANCA, Javier, GARCIA BRAGADO, Federico, DOMINGUEZ FRANJO, Purificación, PIRIS, Miguel A, MONTES-MORENO, Santiago, MARTIN-SANCHEZ, Esperanza, PAJARES, Raquel, SANCHEZ-VERDE, Lydia, ORTIZ-ROMERO, Pablo L, RODRIGUEZ, Jose, RODRIGUEZ-PINILLA, Socorro M, INIESTA-MARTINEZ, Francisca

“…Peripheral T-cell lymphomas (PTCL) are a heterogeneous entity of neoplasms with poor prognosis, a lack of effective therapies, and a largely unknown molecular…”
Get full text

Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30) by Valero-López, Gabriel, Millán-Pascual, Jorge, Iniesta-Martínez, Francisca, Delgado-Marín, Juan L., Jimenez-Veiga, Judith, Tejero-Martín, Ana B., León-Hernández, Adelaida, Zamarro-Parra, Joaquín, Morales-Ortiz, Ana, Meca-Lallana, José E.

“…•Treatment with natalizumab during pregnancy requires careful management.•The NAP-30 protocol is designed to maintain natalizumab efficacy and safety during…”
Get full text

Analysis of disease activity return after natalizumab withdrawal in multiple sclerosis (P3.2-069) by Rumí, Luna Fuentes, Maqueda, Jose Maria Cabrera, Guarnizo, Ester Carreon, Clares, Rocio Hernandez, Isasi, Maria Teresa Alba, Lorenzo, Julian Vazquez, Lorenzo, Gabriel Vazquez, Guerrero, Ana Ester Baidez, de la Prida, Moises Morales, Iniesta, Maria Canovas, Veiga, Judith Jimenez, Hernandez, Adelaida Leon, Marin, Francisca Velazquez, Parra, Joaquin Zamarro, Martinez, Francisca Iniesta, Ortiz, Ana Morales, Lallana, Jose Meca

“…Abstract only…”
Get full text

Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules by Fuentes-Rumí, Luna, Hernández-Clares, Rocío, Carreón-Guarnizo, Ester, Valero-López, Gabriel, Iniesta-Martinez, Francisca, Cabrera-Maqueda, Jose Maria, León-Hernández, Adelaida, Zamarro-Parra, Joaquín, Morales-Ortiz, Ana, Meca-Lallana, José E

“…•The rebound phenomenon, a period of increased disease activity, following natalizumab discontinuation is recognised but its incidence has not been well…”
Get full text

Immunosuppresion following alemtuzumab in relapsing-remitting multiple sclerosis patients previously treated with fingolimod (P4.2-032) by Cabrera-Maqueda, Jose Maria, Rumí, Luna Fuentes, López, Gabriel Valero, Isasi, Teresa Alba, Hernández-Clares, Rocio, Guarnizo, Ester Carreon, Veiga, Judith Jimenez, Iniesta-Martínez, Francisca, León-Hernández, Aida, Parra, Joaquín Zamarro, Ortiz, Ana Morales, Lallana, Jose Meca

“…Abstract only…”
Get full text